Eight-year follow up results of the OTOASOR trial: The optimal treatment of the axilla -surgery or radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer. A randomized, single centre, phase III, non-inferiority trial

被引：0
|
作者：
Savolt, A. [1 ]
Peley, G. [1 ]
Polgar, C. [2 ]
Gyorffy, B. [3 ]
Matrai, Z. [1 ]
机构：
[1] Natl Inst Oncol Hungary, Dept Breast & Sarcoma Surg, Budapest, Hungary
[2] Natl Inst Oncol Hungary, Ctr Radiotherapy, Budapest, Hungary
[3] Hungarian Acad Sci, MTA TTK Momentum Canc Biomarker Res Grp, Budapest, Hungary
来源：
ANNALS OF ONCOLOGY | 2017年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
166P
引用
收藏
页数：1
相关论文
共 36 条
  • [1] Eight-year follow up results of the OTOASOR Trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer. A randomized, single centre, phase III, non-inferiority trial
    Savolt, A.
    Peley, G.
    Csaba, P.
    Udvarhelyi, N.
    Kovacs, E.
    Gyorffy, B.
    Matrai, Z.
    EUROPEAN JOURNAL OF CANCER, 2017, 72 : S1 - S1
  • [2] Eight-year follow up result of the OTOASOR trial: The Optimal Treatment Of the Axilla - Surgery Or Radiotherapy after positive sentinel lymph node biopsy in early-stage breast cancer: A randomized, single centre, phase III, non-inferiority trial
    Savolt, A.
    Peley, G.
    Polgar, C.
    Udvarhelyi, N.
    Rubovszky, G.
    Kovacs, E.
    Gyorffy, B.
    Kasler, M.
    Matrai, Z.
    EJSO, 2017, 43 (04): : 672 - 679
  • [3] Optimal treatment of the axilla after positive sentinel lymph node biopsy in primary invasive breast cancer patients (surgery versus radiotherapy). Final results of the OTOASOR trial. 10 years follow-up of a randomized clinical trial
    Savolt, A.
    Matrai, Z.
    Polgar, C.
    Udvarhelyi, N.
    Sinkovics, I.
    Kovacs, E.
    Peley, G.
    EUROPEAN JOURNAL OF CANCER, 2016, 57 : S15 - S15
  • [4] OPTIMAL TREATMENT OF THE AXILLA AFTER POSITIVE SENTINEL LYMPH NODE BIOPSY IN PRIMARY INVASIVE BREAST CANCER PATIENTS (SURGERY VERSUS RADIOTHERAPY). EARLY RESULTS OF A RANDOMIZED CLINICAL TRIAL
    Peley, G.
    Musonda, P.
    Savolt, A.
    Udvarhelyi, N.
    Sinkovics, I.
    Matrai, Z.
    Renyi-Vamos, F.
    Polgar, C.
    Horvath, Z.
    Szabo, E.
    ANNALS OF ONCOLOGY, 2010, 21 : 5 - 5
  • [5] Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer patients: 10 year follow up results of the EORTC AMAROS trial (EORTC 10981/22023)
    Rutgers, E. J.
    Donker, M.
    Poncet, C.
    Straver, M. E.
    Meijnen, P.
    van de Velde, C. J.
    Mansel, R. E.
    Blanken, C.
    Orzalesi, L.
    Klinkenbijl, J. H.
    van der Mijle, H. C.
    Veltkamp, S. C.
    van 't Riet, M.
    Albregts, M.
    Marinelli, A.
    Rijna, H.
    Morales, R. Tobon
    Snoj, M.
    Bundred, N.
    Chauvet, M. P.
    Merkus, J. W.
    Petignat, P.
    Schinagl, D. A.
    Coens, C.
    Peric, A.
    Bogaerts, J.
    van Tienhoven, G.
    CANCER RESEARCH, 2019, 79 (04)
  • [6] Sentinel Lymph-Node Biopsy in Early-Stage Cervical Cancer: The 4-Year Follow-Up Results of the Senticol 2 Trial
    Favre, Guillaume
    Guani, Benedetta
    Balaya, Vincent
    Magaud, Laurent
    Lecuru, Fabrice
    Mathevet, Patrice
    FRONTIERS IN ONCOLOGY, 2021, 10
  • [7] SENTINEL LYMPH-NODE BIOPSY IN EARLY-STAGE CERVICAL CANCER: THE 4-YEAR FOLLOW-UP RESULTS OF THE SENTICOL 2 TRIAL
    Favre, G.
    Guani, B.
    Balaya, V.
    Magaud, L.
    Lecuru, F.
    Mathevet, P.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2021, 31 : A60 - A60
  • [8] Radiotherapy or surgery of the axilla after a positive sentinel node in breast cancer (EORTC 10981-22023 AMAROS): a randomised, multicentre, open-label, phase 3 non-inferiority trial
    Donker, Mila
    van Tienhoven, Geertjan
    Straver, Marieke E.
    Meijnen, Philip
    van de Velde, Cornelis J. H.
    Mansel, Robert E.
    Cataliotti, Luigi
    Westenberg, A. Helen
    Klinkenbijl, Jean H. G.
    Orzalesi, Lorenzo
    Bouma, Willem H.
    van der Mijle, Huub C. J.
    Nieuwenhuijzen, Grard A. P.
    Veltkamp, Sanne C.
    Slaets, Leen
    Duez, Nicole J.
    de Graaf, Peter W.
    van Dalen, Thijs
    Marinelli, Andreas
    Rijna, Herman
    Snoj, Marko
    Bundred, Nigel J.
    Merkus, Jos W. S.
    Belkacemi, Yazid
    Petignat, Patrick
    Schinagl, Dominic A. X.
    Coens, Corneel
    Messina, Carlo G. M.
    Bogaerts, Jan
    Rutgers, Emiel J. T.
    LANCET ONCOLOGY, 2014, 15 (12): : 1303 - 1310
  • [9] A Randomized Prospective Non-Inferiority Trial of Sentinel Lymph Node Biopsy in Early Breast Cancer: Blue Dye Compared with Indocyanine Green Fluorescence Tracer
    Coibion, Michel
    Olivier, Fabrice
    Courtois, Audrey
    Maes, Nathalie
    Jossa, Veronique
    Jerusalem, Guy
    CANCERS, 2022, 14 (04)
  • [10] Sentinel Lymph Node Biopsy Versus Axillary Dissection in Node-Negative Early-Stage Breast Cancer: 15-Year Follow-Up Update of a Randomized Clinical Trial
    Canavese, Giuseppe
    Bruzzi, Paolo
    Catturich, Alessandra
    Tomei, Daniela
    Carli, Franca
    Garrone, Elsa
    Spinaci, Stefano
    Lacopo, Federico
    Tinterri, Corrado
    Dozin, Beatrice
    ANNALS OF SURGICAL ONCOLOGY, 2016, 23 (08) : 2494 - 2500
1234